InterValve

Intervalve Inc. specializes in the development of advanced aortic valvuloplasty balloon catheters, specifically designed to treat calcific aortic stenosis. The company's flagship product, the TAV8, is a third-generation catheter that builds on the V8 design, enhancing its functionality without altering its operation. The TAV8 is engineered to minimize balloon movement and optimize the aortic valve area, making valvuloplasty procedures more efficient and effective.

Intervalve Inc. primarily serves healthcare providers and medical institutions that perform aortic valvuloplasty procedures. Operating in the medical device market, the company focuses on innovation and quality to meet the needs of its clients. The business model revolves around the development, manufacturing, and sale of specialized medical devices, generating revenue through direct sales and partnerships with medical distributors.

Keywords: aortic valvuloplasty, balloon catheter, calcific aortic stenosis, TAV8, medical device, healthcare, innovation, valve optimization, clinical use, Venus Medtech.